Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Onyx Biotec IPO is a book build issue of ₹29.34 crores. The issue is entirely a fresh issue of 0.48 crore shares of ₹29.34 crore.
Onyx Biotec IPO bidding started from Nov 13, 2024 and ended on Nov 18, 2024. The allotment for Onyx Biotec IPO was finalized on Nov 19, 2024. The shares got listed on NSE SME on Nov 22, 2024.
Onyx Biotec IPO price band is set at ₹61.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an retail is ₹1,16,000 (2000 shares). The minimum lot size investment for HNI is 2 lots (4,000 shares), amounting to ₹2,44,000.
Horizon Management Pvt.Ltd. is the book running lead manager and MAS Services Ltd. is the registrar of the issue. The market maker of the company is Giriraj Stock Broking Pvt.Ltd..
Refer to Onyx Biotec IPO RHP for detailed Information.
| IPO Date | November 13, 2024 to November 18, 2024 |
| Listing Date | November 22, 2024 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹58 to ₹61 per share |
| Issue Price Final | ₹61 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 48,10,000 shares (aggregating up to ₹29.34 Cr) |
| Reserved for Market Maker | 2,44,000 shares Giriraj Stock Broking Pvt.Ltd. (aggregating up to ₹1.49 Cr) |
| Net Offered to Public | 45,66,000 shares (aggregating up to ₹27.85 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,33,22,200 shares |
| Share Holding Post Issue | 1,81,32,200 shares |
Onyx Biotec IPO offers total 48,10,000 shares. Out of which 22,78,000 (47.36%) allocated to QIB, 9,12,000 (18.96%) allocated to QIB, 6,88,000 (14.30%) allocated to NII, 16,00,000 (33.26%) allocated to RII and 13,66,000 (28.40%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 2,44,000 (5.07%) |
| QIB Shares Offered | 22,78,000 (47.36%) |
| − Anchor Investor Shares Offered | 13,66,000 (28.40%) |
| − QIB (Ex. Anchor) Shares Offered | 9,12,000 (18.96%) |
| NII (HNI) Shares Offered | 6,88,000 (14.30%) |
| Retail Shares Offered | 16,00,000 (33.26%) |
| Total Shares Offered | 48,10,000 (100.00%) |
Onyx Biotec IPO raises ₹8.33 crore from anchor investors. Onyx Biotec IPO Anchor bid date is November 12, 2024. Onyx Biotec IPO Anchor Investors list
| Bid Date | November 12, 2024 |
| Shares Offered | 13,66,000 |
| Anchor Portion Size (In Cr.) | 8.33 |
| Anchor lock-in period end date for 50% shares (30 Days) | December 19, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | February 17, 2025 |
Onyx Biotec IPO opens on November 13, 2024, and closes on November 18, 2024.
| IPO Open Date | Wed, Nov 13, 2024 |
| IPO Close Date | Mon, Nov 18, 2024 |
| Tentative Allotment | Tue, Nov 19, 2024 |
| Initiation of Refunds | Wed, Nov 20, 2024 |
| Credit of Shares to Demat | Wed, Nov 20, 2024 |
| Tentative Listing Date | Fri, Nov 22, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on Mon, Nov 18, 2024 |
Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,22,000 |
| Retail (Max) | 1 | 2,000 | ₹1,22,000 |
| HNI (Min) | 2 | 4,000 | ₹2,44,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company providing sterile water for injections. The company currently manufactures Sterile Water for Injections and serves as a pharmaceutical contract manufacturer, offering a comprehensive range of Dry Powder Injections and Dry Syrups for both the Indian and overseas markets.
The company has two manufacturing units in Solan, Himachal Pradesh. Unit I has a daily production capacity of 638,889 units of Sterile Water for Injections, while Unit II produces 40,000 units of dry powder injections and 26,667 units of dry syrup per day in a single shift.
The company clientele includes Hetero Healthcare Limited, Mankind Pharma Limited, Sun Pharmaceutical Industries Limited, Aristo Pharmaceuticals Private Limited, Macleods Pharmaceuticals Limited, Mapra Laboratories Private Limited, Axa Parenterals Limited, FDC Limited, Zuventus Healthcare Limited, Akums Drugs and Pharmaceuticals Limited, Reliance Life Sciences Limited, among others.
As of May 31, 2024, the company had a client base of more than 100 Indian and multinational pharmaceutical companies.
The company has received certificates for the management system, ISO 9001:2015, and ISO 14001:2015 from ROHS Certification Private Limited.
As of July 31, 2024, the company has 175 employees across various departments.
Onyx Biotec Limited's revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 31 May 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 7,476.57 | 7,413.58 | 5,872.36 | 3,683.84 |
| Total Income | 1,054.11 | 5,387.43 | 3,961.65 | 4,498.09 |
| Profit After Tax | 130.77 | 303.16 | 184.46 | 335.29 |
| Net Worth | 2,618.64 | 2,487.87 | 1,820.16 | 1,637.59 |
| Reserves and Surplus | 1,286.42 | 1,155.65 | 1,230.00 | 1,047.43 |
| Total Borrowing | 3,156.14 | 3,078.04 | 2,922.83 | 1,224.39 |
| Amount in ₹ Lakhs | ||||
The market capitalization of Onyx Biotec IPO is ₹110.61 Cr.
KPI as of Fri, May 31, 2024.
| KPI | Values |
|---|---|
| ROE | 4.99% |
| ROCE | 3.71% |
| Debt/Equity | 1.21 |
| RoNW | 4.99% |
| PAT Margin | 12.42% |
| Price to Book Value | 3.10 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 2.28 | 4.33 |
| P/E (x) | 26.81 | 14.1 |
The Company proposes to utilize the Net Proceeds from the Issue towards the following objects:
[Dilip Davda] The company is engaged in a highly competitive and fragmented segment of sterile water, dry power-syrup products. It marked inconsistency in its top lines for the reported periods. Highly fluctuating bottom lines raises eyebrows. Based on FY25 super earnings, the issue appears fully priced. Well-informed investors may park moderate funds for long term. Read detail review...
| Listing Date | November 22, 2024 |
| BSE Script Code | |
| NSE Symbol | ONYX |
| ISIN | INE0WVU01018 |
| Final Issue Price | ₹61 per share |
| NSE Listing Group | ST |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹61.00 |
| Open | ₹54.05 |
| Low | ₹51.45 |
| High | ₹56.75 |
| Last Trade | ₹56.75 |
Onyx Biotec Ltd.
Bir Plassi
Near Sainimajraropar
Nalagarh Road
Solan, Himachal Pradesh, 174101
Phone: +91 172 265 6384
Email: generalinfo@onyxbiotec.com
Website: http://www.onyxbiotec.com/
MAS Services Ltd.
Phone: (011) 2610 4142
Email: ipo@masserv.com
Website: https://www.masserv.com/opt.asp
Onyx Biotec IPO is a SME IPO of 48,10,000 equity shares of the face value of ₹10 aggregating up to ₹29.34 Crores. The issue is priced at ₹61 per share. The minimum order quantity is 2000.
The IPO opens on November 13, 2024, and closes on November 18, 2024.
MAS Services Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Onyx Biotec IPO using UPI as a payment gateway. Zerodha customers can apply in Onyx Biotec IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Onyx Biotec IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Onyx Biotec IPO opens on November 13, 2024 and closes on November 18, 2024.
Onyx Biotec IPO lot size is 2000, and the minimum amount required for application is ₹1,22,000.
You can apply in Onyx Biotec IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Onyx Biotec IPO will be done on Tuesday, November 19, 2024, and the allotted shares will be credited to your demat account by Wednesday, November 20, 2024. Check the Onyx Biotec IPO allotment status.
The Onyx Biotec IPO listing date is on Friday, November 22, 2024.
Useful Articles
RHP